Other OTC - Delayed Quote USD

SomnoMed Limited (SOMNF)

0.2800 0.0000 (0.00%)
At close: January 19 at 3:26 PM EST
Loading Chart for SOMNF
DELL
  • Previous Close 0.2800
  • Open 0.2800
  • Bid --
  • Ask --
  • Day's Range 0.2800 - 0.2800
  • 52 Week Range 0.2800 - 0.7900
  • Volume 3,000
  • Avg. Volume 0
  • Market Cap (intraday) 38.102M
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively. In addition, it also provides sleep test at home under the Sunrise brand name. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

somnomed.com/au/

--

Full Time Employees

June 30

Fiscal Year Ends

Recent News: SOMNF

Performance Overview: SOMNF

Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SOMNF
28.21%
S&P/ASX 200 [XJO]
0.31%

1-Year Return

SOMNF
64.56%
S&P/ASX 200 [XJO]
2.74%

3-Year Return

SOMNF
80.00%
S&P/ASX 200 [XJO]
7.10%

5-Year Return

SOMNF
77.60%
S&P/ASX 200 [XJO]
20.89%

Compare To: SOMNF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SOMNF

Valuation Measures

As of 4/19/2024
  • Market Cap

    19.23M

  • Enterprise Value

    22.89M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.56

  • Price/Book (mrq)

    1.98

  • Enterprise Value/Revenue

    0.26

  • Enterprise Value/EBITDA

    -30.17

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.94%

  • Return on Assets (ttm)

    -6.34%

  • Return on Equity (ttm)

    -38.28%

  • Revenue (ttm)

    88.77M

  • Net Income Avi to Common (ttm)

    -10.51M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.84M

  • Total Debt/Equity (mrq)

    62.00%

  • Levered Free Cash Flow (ttm)

    -6.26M